Safety and efficacy of IBI362 (LY3305677) in Chinese patients with T2D: A randomized, placebo-controlled phase 1b studyW. Yang,H. Jiang,T. Yu,M. Liu,H. Deng,F. Liqi,L. Li,L. QianDIABETES RESEARCH AND CLINICAL PRACTICE（2022）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
